PetMed ExpressPETS +6.08%56 Buyback Yield % is 0.00 as of Jun. 30, 2026. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.87 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 271 Healthcare Providers & Services companies, PetMed Express ranks worse than 369003.32% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for PetMed Express's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PETS vs SHFH, BHIC, SCNX: Buyback Yield % Comparison
For the Pharmaceutical Retailers subindustry, PetMed Express's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where PetMed Express's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetMed Express (PETS) has a Buyback Yield % of 0.00 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PetMed Express and its competitors. Over the past decade, PetMed Express' Buyback Yield % has ranged from 1.98 to 3.66. According to the industry distribution chart, PetMed Express ranks #999999 out of 271 companies in the Healthcare Providers & Services industry.
Is PetMed Express' Buyback Yield % too high?
PetMed Express' current Buyback Yield % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.98 to a high of 3.66. Based on the distribution chart, PetMed Express ranks #999999 out of 271 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Buyback Yield % compare to SHFH and BHIC?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #999999 out of 271 companies for Buyback Yield %. This places PetMed Express in the lower half of its industry. Historically, PetMed Express' own Buyback Yield % has ranged from 1.98 to 3.66 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PetMed Express and its competitors. PetMed Express's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.87, compared to a current price of $1.92 — trading 33.1% below its estimated fair value. The current Buyback Yield % is 0.00. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For PetMed Express (PETS), the current Buyback Yield % is 0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $1.92 is trading 33.1% below its estimated GF Value™ of $2.87.
GuruFocus considers PetMed Express to be Possible Value Trap.
Key valuation signals for PETS:
Buyback Yield %: 0.00
GF Value™: $2.87 vs. price of $1.92 (33.1% below fair value)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 
